World Vaccine Congress Washington, April 7-9 2015

Download eBook: Discussion topics from Pandemic Influenza, 2nd Edition

Pandemic influenza is a re-emerging disease with serious public health consequences. The H1N1 pandemic in 2009-10 and the continuing threat to humans from avian influenza H5N1 and H5N8 have underlined this threat. Particularly in an increasingly globalised society, it is essential that we have preparedness plans in please at a local, national and international level. Download this eBook to: Gain …

World Vaccine Congress Washington 2015

Download: ‘Vaccine Insights’ eBook, interviews with the leaders of the vaccine industry

The world of vaccine development is changing. Personalised medicine is making huge waves in the industry, and from this we have seen the rise of therapeutic vaccines for diseases such as cancer. Alongside this, the Ebola crisis has caused all stakeholders to re-evaluate the processes for research and manufacture of vaccines to ensure that they can roll them out as …

Retroscreen Virology Senior Medical Director to speak at World Vaccine Congress USA 2015

The world’s leading research company in human viral challenge models, Retroscreen Virology, has announced one of its scientific and medical leadership team will be speaking at 2015 World Vaccine Congress in the USA. Dr Martin Johnson, Senior Medical Director at Retroscreen Virology, is going to be talking about the Retroscreen hVIVO human viral challenge model and how it can be …

Treating Dengue, Schistosomiasis, Chagas Disease and Leishmaniasis

According to PAHO/WHO neglected or ‘forgotten’ infectious diseases are often parasitic diseases which primarily affect the most vulnerable communities. These illnesses often impact on those living in extreme poverty who have terrible access to health services, particularly those in very rural areas or shantytowns. These factors of being poor and being marginalised exacerbate the consequences of the disease compared with …

World Vaccine Congress Brochure Available

  The World Vaccine Congress Washington is now in its 15th year, and things look a little different to previous years. ‘So why the change?’ I hear you ask… In my previous role, we produced very focused agendas and ran two-day events specifically on that area. This would be as niche as talking only about foundations for deep water offshore …

Inovio Presents Phase II Clinical Efficacy Data at the 15th World Vaccine Congress

With the 15th World Vaccine Congress on 13 – 15 October in Brussels is just next month I conducted an interview to one of our key speakers, Dr. Niranjan Y. Sardesai (COO, Inovio Pharmaceuticals, Inc.) to give you further insight into his new exciting clinical data and current challenges in developing cancer DNA vaccines.  Dr. Sardesai has broad development and …

vaccine manufacturers

Top 3 Sparks of Interest for Leading Vaccine Academics

Recently we undertook the research for the 15th annual World Vaccine Congress. As part of that research, we spoke to leading vaccine academics from the likes of University of Oxford and Erasmus MC to find out what they thought were the most interesting trends in industry at the moment. These were the top 3: 1. The renaissance of veterinary vaccines …